Inventor · disambiguated record
Calum Macleod
Also filed as: MACLEOD CALUM
30 granted patents·12 pending applications·74 citations·filing 2009–2025
95Inventor score
Top patents by PatentIndex Score
42 records- 0196US9650393B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2016·Granted May 16, 2017·20 cites·23 claims
- 0295US9440976B21,7-diazacarbazoles and methods of useGENENTECH INC·Filed 2015·Granted Sep 13, 2016·10 cites·5 claims
- 0394US10851091B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2018·Granted Dec 1, 2020·5 cites·3 claims
- 0493US11760753B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2020·Granted Sep 19, 2023·2 cites·17 claims
- 0592US10112932B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2017·Granted Oct 30, 2018·8 cites·9 claims
- 0689US2025197386A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2024·Application pending·0 cites
- 0788US2025326745A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 0886US2024199594A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 0984US9643964B23-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancerJANSSEN PHARMACEUTICA NV·Filed 2014·Granted May 9, 2017·9 cites·15 claims
- 1081US9309240B2Pyrazolopyridine compounds, compositions and methods of useHOFFMANN LA ROCHE·Filed 2013·Granted Apr 12, 2016·6 cites·16 claims
- 1180US9643980B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2016·Granted May 9, 2017·3 cites·21 claims
- 1280US8501765B2Diazacarbazoles and methods of useCHEN HUIFEN·Filed 2009·Granted Aug 6, 2013·4 cites·37 claims
- 1379US11492347B2Fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Nov 8, 2022·1 cites·12 claims
- 1474US8697708B2Azabenzothiazole compounds, compositions and methods of useBLENCH TOBY JONATHAN·Filed 2011·Granted Apr 15, 2014·3 cites·1 claims
- 1570US11279683B2Thiophene derivatives as antiviral agentsENYO PHARMA·Filed 2017·Granted Mar 22, 2022·1 cites·9 claims
- 1670US10065970B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Granted Sep 4, 2018·1 cites·18 claims
- 1766US2014171407A11,7-diazacarbazoles and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 1864US10822342B2Pyrazolopyrimidine derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 3, 2020·0 cites·12 claims
- 1963US11807618B2Thiophene derivatives as antiviral agentsENYO PHARMA·Filed 2022·Granted Nov 7, 2023·0 cites·7 claims
- 2063US2017210733A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 2162US2011124654A1Diazacarbazoles and methods of useCHEN HUIFEN·Filed 2009·Application pending·0 cites
- 2261US8546376B2Pharmaceutical compoundsBELL MARK PETER·Filed 2010·Granted Oct 1, 2013·1 cites·16 claims
- 2360US11603368B2Fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Mar 14, 2023·0 cites·2 claims
- 2459US11186589B2Cyanoindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 30, 2021·0 cites·20 claims
- 2558US9216980B2Methods of use of diazacarbazoles for treating cancerGENENTECH INC·Filed 2014·Granted Dec 22, 2015·0 cites·37 claims
- 2655US2013261104A1Methods of use of diazacarbazoles for treating cancerGENENTECH INC·Filed 2013·Application pending·0 cites
- 2753US2019119299A1Cyanoindoline derivatives as nik inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2853US2015368244A1Diazacarbazoles and methods of useGENENTECH INC·Filed 2013·Application pending·0 cites
- 2952US2014171408A1Azabenzothiazole compounds, compositions and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 3050US10435414B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2018·Granted Oct 8, 2019·0 cites·23 claims
- 3148US11236084B2Substituted azaindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Feb 1, 2022·0 cites·15 claims
- 3248US2022289751A1Compound having kdm5 inhibitory activity and pharmaceutical use thereofONO PHARMACEUTICAL CO·Filed 2020·Application pending·0 cites
- 3345US10005773B21-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 26, 2018·0 cites·29 claims
- 3445US9981963B23-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted May 29, 2018·0 cites·20 claims
- 3544US10221180B2Pyrazolopyrimidine derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Mar 5, 2019·0 cites·13 claims
- 3644US2020339548A1Pyrimidine derivatives and their use for the treatment of cancerADORX THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 3741US10323045B2Thienopyrimidine derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jun 18, 2019·0 cites·24 claims
- 3839US11180487B2Substituted cyanoindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 23, 2021·0 cites·15 claims
- 3939US11136311B2Heteroaromatic derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 5, 2021·0 cites·15 claims
- 4039US11001569B26-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 11, 2021·0 cites·8 claims
- 4137US10005776B2Compounds as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jun 26, 2018·0 cites·5 claims
- 4235US9981962B2Pyrazole derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted May 29, 2018·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Calum Macleod files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →